Skip to main content
. Author manuscript; available in PMC: 2013 Nov 7.
Published in final edited form as: J Immunol. 2013 Jan 4;190(3):10.4049/jimmunol.1200593. doi: 10.4049/jimmunol.1200593

FIGURE 5.

FIGURE 5

Hsp90 inhibition decreases SEB-induced T lymphocyte IFN-γ production and cellular activation. Human CD3+ T lymphocytes stimulated with SEB (1 μg/ml) were treated with geldanamycin and then evaluated for intracellular IFN-γ production and cell activation by flow cytometry. Hsp90 inhibition resulted in a dramatic decrease in IFN-γ production and activation (CD69+) in both CD4+ and CD8+ T lymphocyte subsets.